Literature DB >> 29341148

Outcomes after prophylactic gastrectomy for hereditary diffuse gastric cancer.

R T van der Kaaij1, J P van Kessel1, J M van Dieren2, P Snaebjornsson3, O Balagué3, F van Coevorden1, L E van der Kolk4, K Sikorska5, A Cats2, J W van Sandick1.   

Abstract

BACKGROUND: Patients with hereditary diffuse gastric cancer and a CDH1 mutation have a 60-80 per cent lifetime risk of developing diffuse gastric cancer. Total prophylactic gastrectomy eliminates this risk, but is associated with considerable morbidity. The effectiveness (removal of all gastric mucosa) and outcomes of this procedure were evaluated retrospectively.
METHODS: All consecutive individuals undergoing a prophylactic gastrectomy for a CDH1 mutation or gastric signet ring cell foci at the authors' institute between 2005 and 2017 were included.
RESULTS: In 25 of 26 patients, intraoperative frozen-section examination (proximal resection margin) was used to verify complete removal of gastric mucosa. All definitive resection margins were free of gastric mucosa, but only after the proximal margin had been reresected in nine patients. In the first year after surgery, five of the 26 patients underwent a relaparotomy for adhesiolysis (2 patients) or jejunostomy-related complications (3 patients). Six patients were readmitted to the hospital within 1 year for nutritional and/or psychosocial support (4 patients) or surgical reintervention (2 patients). Mean weight loss after 1 year was 15 (95 per cent c.i. 12 to 18) per cent. For the 25 patients with a follow-up at 1 year or more, functional complaints were reported more frequently at 1 year than at 3 months after the operation: bile reflux (15 versus 11 patients respectively) and dumping (11 versus 7 patients). The majority of patients who worked or studied before surgery (15 of 19) had returned fully to these activities within 1 year.
CONCLUSION: The considerable morbidity and functional consequences of gastrectomy should be considered when counselling individuals with an inherited predisposition to diffuse gastric cancer. Intraoperative frozen-section examination is recommended to remove all risk-bearing gastric mucosa.
© 2018 BJS Society Ltd Published by John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29341148     DOI: 10.1002/bjs.10754

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  7 in total

1.  CDH1 on Multigene Panel Testing: Look Before You Leap.

Authors:  Bryson W Katona; Dana Farengo Clark; Susan M Domchek
Journal:  J Natl Cancer Inst       Date:  2020-04-01       Impact factor: 13.506

2.  Morbidity and Mortality of Total Gastrectomy: a Comprehensive Analysis of 90-Day Outcomes.

Authors:  Selena S Li; Christina L Costantino; John T Mullen
Journal:  J Gastrointest Surg       Date:  2019-05-06       Impact factor: 3.452

Review 3.  Hereditary diffuse gastric cancer: updated clinical practice guidelines.

Authors:  Vanessa R Blair; Maybelle McLeod; Fátima Carneiro; Daniel G Coit; Johanna L D'Addario; Jolanda M van Dieren; Kirsty L Harris; Nicoline Hoogerbrugge; Carla Oliveira; Rachel S van der Post; Julie Arnold; Patrick R Benusiglio; Tanya M Bisseling; Alex Boussioutas; Annemieke Cats; Amanda Charlton; Karen E Chelcun Schreiber; Jeremy L Davis; Massimiliano di Pietro; Rebecca C Fitzgerald; James M Ford; Kimberley Gamet; Irene Gullo; Richard H Hardwick; David G Huntsman; Pardeep Kaurah; Sonia S Kupfer; Andrew Latchford; Paul F Mansfield; Takeshi Nakajima; Susan Parry; Jeremy Rossaak; Haruhiko Sugimura; Magali Svrcek; Marc Tischkowitz; Toshikazu Ushijima; Hidetaka Yamada; Han-Kwang Yang; Adrian Claydon; Joana Figueiredo; Karyn Paringatai; Raquel Seruca; Nicola Bougen-Zhukov; Tom Brew; Simone Busija; Patricia Carneiro; Lynn DeGregorio; Helen Fisher; Erin Gardner; Tanis D Godwin; Katharine N Holm; Bostjan Humar; Caroline J Lintott; Elizabeth C Monroe; Mark D Muller; Enrique Norero; Yasmin Nouri; Joana Paredes; João M Sanches; Emily Schulpen; Ana S Ribeiro; Andrew Sporle; James Whitworth; Liying Zhang; Anthony E Reeve; Parry Guilford
Journal:  Lancet Oncol       Date:  2020-08       Impact factor: 41.316

Review 4.  Hereditary diffuse gastric cancer: how to look for and how to manage it.

Authors:  Karol Polom; Daniele Marrelli; Alessia D'Ignazio; Franco Roviello
Journal:  Updates Surg       Date:  2018-06-04

Review 5.  Hereditary Gastric and Breast Cancer Syndromes Related to CDH1 Germline Mutation: A Multidisciplinary Clinical Review.

Authors:  Giovanni Corso; Giacomo Montagna; Joana Figueiredo; Carlo La Vecchia; Uberto Fumagalli Romario; Maria Sofia Fernandes; Susana Seixas; Franco Roviello; Cristina Trovato; Elena Guerini-Rocco; Nicola Fusco; Gabriella Pravettoni; Serena Petrocchi; Anna Rotili; Giulia Massari; Francesca Magnoni; Francesca De Lorenzi; Manuela Bottoni; Viviana Galimberti; João Miguel Sanches; Mariarosaria Calvello; Raquel Seruca; Bernardo Bonanni
Journal:  Cancers (Basel)       Date:  2020-06-17       Impact factor: 6.639

6.  Four cases of gastric adenocarcinoma and proximal polyposis of the stomach treated by robotic total gastrectomy.

Authors:  Yosuke Iwakawa; Kozo Yoshikawa; Koichi Okamoto; Tetsuji Takayama; Takuya Tokunaga; Toshihiro Nakao; Masaaki Nishi; Chie Takasu; Hideya Kashihara; Yuma Wada; Toshiaki Yoshimoto; Shoko Yamashita; Mitsuo Shimada
Journal:  Surg Case Rep       Date:  2022-04-18

7.  Barriers and facilitators to CDH1 carriers contemplating or undergoing prophylactic total gastrectomy.

Authors:  Kaitlin M McGarragle; Tae L Hart; Carol Swallow; Savtaj Brar; Anand Govindarajan; Zane Cohen; Melyssa Aronson
Journal:  Fam Cancer       Date:  2020-08-05       Impact factor: 2.375

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.